Moderna CEO on New Flu Vaccine, Curing Cancer

The transcript discusses the future of vaccines, focusing on respiratory diseases like COVID, RSV, and flu, and the potential launch of a cancer product. It covers financial aspects, market risks, and the importance of vaccine uptake. The conversation highlights future opportunities in healthcare, particularly in respiratory and cancer treatments, and innovations like liquid biopsy for early cancer detection. The role of data and AI in diagnostics and personalized treatment is emphasized, showcasing advancements in healthcare technology.

What role do insurance companies play in the pricing of cancer treatments?

What are the financial implications of early cancer detection mentioned?

How does Moderna plan to utilize data from diagnostic companies?